Literature DB >> 21029177

Pheochromocytoma presenting with Takotsubo syndrome.

Pamela A Marcovitz1, Peter Czako, Solomon Rosenblatt, Scott S Billecke.   

Abstract

The clinical presentation of Takotsubo syndrome, or apical ballooning syndrome, resembles an extensive anterolateral myocardial infarction with chest pain symptoms and electrocardiographic ST-elevation or T-wave inversion noted in most patients. However, coronary arteries are invariably found to be normal or to display minimal atherosclerotic disease despite modest elevation of cardiac enzymes. Since most cases of Takotsubo syndrome occur after intense physical and/or emotional stress, catecholamine surge appears to be a common underlying mechanism. We present a case of Takotsubo syndrome, which presented with unusual symptoms and was found to be caused by pheochromocytoma. A sudden rise in blood pressure moments after completion of echocardiographic stress testing aided in uncovering the diagnosis. ©2010, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21029177     DOI: 10.1111/j.1540-8183.2010.00551.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  13 in total

Review 1.  Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment.

Authors:  Kazuo Komamura; Miho Fukui; Toshihiro Iwasaku; Shinichi Hirotani; Tohru Masuyama
Journal:  World J Cardiol       Date:  2014-07-26

Review 2.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.

Authors:  Horacio Medina de Chazal; Marco Giuseppe Del Buono; Lori Keyser-Marcus; Liangsuo Ma; F Gerard Moeller; Daniel Berrocal; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2018-10-16       Impact factor: 24.094

3.  Pheochromocytoma presenting as acute decompensated heart failure reversed with medical therapy.

Authors:  Christopher M Mulla; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-07-19

4.  Pheochromocytoma crisis presenting with cardiogenic shock.

Authors:  Y S Chatzizisis; A Ziakas; C Feloukidis; D Paramythiotis; S Hadjimiltiades; A Iliadis; G Basdanis; I Styliadis
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

5.  Apical ballooning with mid-ventricular obstruction: the many faces of Takotsubo cardiomyopathy.

Authors:  Veronica Spadotto; Mohamed Elmaghawry; Alessandro Zorzi; Federico Migliore; Martina Perazzolo Marra
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

6.  Clinical features of patients with stress-induced cardiomyopathy associated with renal dysfunction: 7 case series in single center.

Authors:  Min Ji Shin; Harin Rhee; Il Young Kim; Byeong Yun Yang; Sang Heon Song; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Jung Hyun Choi; Eun Young Seong
Journal:  BMC Nephrol       Date:  2013-10-07       Impact factor: 2.388

Review 7.  Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: A case report and literature review.

Authors:  Yi-Lun Chiang; Pei-Chi Chen; Chin-Cheng Lee; Su-Kiat Chua
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Congestive heart failure and upper extremity deep vein thrombosis: A rare presentation of a pheochromocytoma.

Authors:  Eman M Alfadhli
Journal:  J Taibah Univ Med Sci       Date:  2020-05-01

9.  Phaeochromocytoma crisis: two cases of undiagnosed phaeochromocytoma presenting after elective nonrelated surgical procedures.

Authors:  P C Johnston; J A Silversides; H Wallace; P A Farling; A Hutchinson; S J Hunter; F Eatock; K R Mullan
Journal:  Case Rep Anesthesiol       Date:  2013-10-28

Review 10.  Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.

Authors:  Marie Batisse-Lignier; Bruno Pereira; Pascal Motreff; Romain Pierrard; Christelle Burnot; Charles Vorilhon; Salwan Maqdasy; Béatrice Roche; Francoise Desbiez; Guillaume Clerfond; Bernard Citron; Jean-René Lusson; Igor Tauveron; Romain Eschalier
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.